A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED SAFETY STUDY EVALUATING THE EFFECTS OF RESIDUAL RENAL FUNCTION (RFF) IN PATIENTS WITH END-STAGE RENAL DISEASE AND TYPE 2 DIABETES MELLITUS ON PERITONEAL DIALYSIS: